Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 283 entries
View as:

Whole Versus Partial Vertebral Body IMRT for Spinal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02972229 Org: User:
Start: 11/30/16 End: 11/30/19 Due: 11/30/20

The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

Phase: N/A Priority: Normal
NCT ID: NCT03164005 Org: User:
Start: 04/20/17 End: 03/01/18 Due: 03/01/19

The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial

Phase: N/A Priority: Normal
NCT ID: NCT06785571 Org: User:
Start: 08/30/23 End: 10/31/25 Due: 10/31/26

The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT06346938 Org: User:
Start: 03/26/24 End: 03/26/27 Due: 03/26/28

A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05998928 Org: User:
Start: 07/27/23 End: 07/27/26 Due: 07/27/27

Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation

Phase: N/A Priority: Normal
NCT ID: NCT03135652 Org: User:
Start: 08/01/17 End: 06/01/23 Due: 06/01/24

The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression

Phase: N/A Priority: Normal
NCT ID: NCT05861635 Org: User:
Start: 02/01/23 End: 02/01/26 Due: 02/01/27

Multicenter Application of the Intraoperative Hypothermia Risk Prediction Scale and the Distribution of Risk Factor Characteristics in Surgical Patients

Phase: N/A Priority: Normal
NCT ID: NCT06836245 Org: User:
Start: 09/15/24 End: 04/30/25 Due: 04/30/26

Analysis of Metabonomics for Pleural Effusion

Phase: N/A Priority: Normal
NCT ID: NCT05906823 Org: User:
Start: 01/01/16 End: 01/01/23 Due: 01/01/24

Myocardial Damage in COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04312464 Org: User:
Start: 01/01/20 End: 03/18/20 Due: 03/18/21

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05674539 Org: User:
Start: 02/15/23 End: 12/30/25 Due: 12/30/26

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04231552 Org: User:
Start: 11/10/19 End: 09/30/23 Due: 09/30/24

A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06106893 Org: User:
Start: 01/12/24 End: 12/31/27 Due: 12/31/28

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06693973 Org: User:
Start: 12/27/23 End: 01/13/26 Due: 01/13/27

Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies

Phase: N/A Priority: Normal
NCT ID: NCT06220097 Org: User:
Start: 02/01/24 End: 12/30/25 Due: 12/30/26

ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04014894 Org: User:
Start: 06/12/19 End: 07/01/22 Due: 07/01/23

Study on the Effect of Target-controlled Infusion for General Anesthesia in Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06012955 Org: User:
Start: 08/30/23 End: 06/30/24 Due: 06/30/25

Fecal Microbiota and Monocyte Trained Immunity in CHD Patients With Different hsCRP

Phase: N/A Priority: Normal
NCT ID: NCT06562309 Org: User:
Start: 05/11/21 End: 07/15/24 Due: 07/15/25

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03614065 Org: User:
Start: 02/21/17 End: 11/30/18 Due: 11/30/19

Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06400537 Org: User:
Start: 07/20/24 End: 05/31/26 Due: 05/31/27

A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06975462 Org: User:
Start: 06/01/25 End: 12/01/27 Due: 12/01/28

Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06653478 Org: User:
Start: 06/01/22 End: 10/01/26 Due: 10/01/27

Evaluating the Effectiveness and Safety of Colon Capsule Endoscope System for Capturing and Viewing Colon Images

Phase: N/A Priority: Normal
NCT ID: NCT05308511 Org: User:
Start: 04/01/22 End: 08/04/23 Due: 08/04/24

Analysis of the Cost-Effectiveness of Same-day Discharge Surgery for Primary Total Hip Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT04900181 Org: User:
Start: 07/01/20 End: 07/15/21 Due: 07/15/22

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06125171 Org: User:
Start: 01/31/24 End: 12/31/25 Due: 12/31/26